Skip to main content

Table 1 Correlation between miR-122-5p expression and clinicopathological features in 60 PDAC patients

From: MicroRNA-122-5p inhibits cell proliferation, migration and invasion by targeting CCNG1 in pancreatic ductal adenocarcinoma

Variables

No. of cases (n = 60)

MiR-122-5p expression

P-value

Low (n = 33)

High (n = 27)

Gender

   

0.895

 Male

35

19

16

 

 Female

25

14

11

 

Age

   

0.875

 < 60

26

14

12

 

 ≥ 60

34

19

15

 

TNM stage

   

0.011

 I–II

15

4

11

 

 III–IV

45

29

16

 

Tumor size

   

0.014

 < 5

44

20

24

 

 ≥ 5

16

13

3

 

Lymph node metastasis

   

0.006

 Yes

36

25

11

 

 No

24

8

16

 

Differentiation

   

0.082

 High

14

9

5

 

 Moderate

22

15

7

 

 Low

24

9

15

 

CCNG1

   

0.011

 Positive

33

23

10

 

 Negative

27

10

17

 
  1. PDAC pancreatic ductal adenocarcinoma, TNM tumor-node-metastasis